Brian E. Ward
President chez Advantage Genomics LLC
Profil
Brian E.
Ward is a Member of the American College of Medical Genetics & Genomics and the President of Advantage Genomics LLC.
He was the Chief Executive Officer & Director of Diadexus, Inc. from 2014 to 2015.
He was also the Senior Vice President-Development of Genomic Health, Inc. and the Executive Vice President of The DNA Repair Co. He was a Principal at the University of Colorado Health Sciences Center and Genzyme Genetics, Inc. He was the SVP-Medical Genetic Services & Operations of Myriad Genetic Laboratories, Inc. He was the Chief Operating Officer of On-Q-ity, Inc. from 2008 to 2014.
Dr. Ward received his undergraduate degree from the University of Wisconsin and his graduate and doctorate degrees from the University of Colorado Health Sciences Center.
Postes actifs de Brian E. Ward
Sociétés | Poste | Début |
---|---|---|
American College of Medical Genetics & Genomics | Corporate Officer/Principal | - |
Advantage Genomics LLC | President | 27/06/2011 |
Anciens postes connus de Brian E. Ward
Sociétés | Poste | Fin |
---|---|---|
DIADEXUS, INC. | Directeur Général | 01/01/2015 |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Directeur des opérations | 14/01/2014 |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | Corporate Officer/Principal | 03/11/2009 |
GENOMIC HEALTH, INC. | Corporate Officer/Principal | - |
University of Colorado Health Sciences Center | Corporate Officer/Principal | - |
Formation de Brian E. Ward
University of Wisconsin | Undergraduate Degree |
University of Colorado Health Sciences Center | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 7 |
---|---|
Genomic Health, Inc.
Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
The DNA Repair Co.
The DNA Repair Co. Medical/Nursing ServicesHealth Services The DNA Repair Co. develops cancer diagnostics solutions. The firm produces DNA Repair biomarkers which reveal therapeutic solutions for cancer drugs. The company was founded by Alan D’Andrea, William A. Haseltine, Michael B. Yaffe, and Markus Grompe and is headquartered in Boston, MA. | Health Services |
Genzyme Genetics, Inc.
Genzyme Genetics, Inc. Medical/Nursing ServicesHealth Services Genzyme Genetics, Inc. provides laboratory testing and diagnostic services specifically for reproductive and oncology tests. It provides tests for cystic fibrosis carriers and cancers. The company is headquartered in Westborough, MA. | Health Services |
Myriad Genetic Laboratories, Inc.
Myriad Genetic Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Myriad Genetic Laboratories, Inc. provides cancer predisposition testing services. It operates as a biopharmaceutical company that focuses on developing therapeutic and predictive medicine products. The company was founded on October 11, 1995 and is headquartered in Salt Lake City, UT. | Commercial Services |
On-Q-ity, Inc.
On-Q-ity, Inc. Medical/Nursing ServicesHealth Services On-Q-ity is an innovative diagnostic company that is focused on providing physicians with the tools they need to make the best decision when treating individual cancer patients. Its circulating tumor cell technology will enable better decision-making across multiple cancers: improving the quality of life for patients and ultimately increasing survival. On-Q-ity's products and services are based on its unique and proprietary circulating tumor cell (CTC) technology which enables them to capture, count and characterize CTCs from a sample of patient blood. Through proprietary circulating tumor cell (CTC) and biomarker technology, they are creating products designed to non-invasively monitor and optimize cancer care throughout the disease cycle. They invite companies with complementary technologies, innovative biomarkers, and special expertise in its field to explore partnering relationships. | Health Services |
Diadexus, Inc.
Diadexus, Inc. BiotechnologyHealth Technology Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA. | Health Technology |
Advantage Genomics LLC |